Project
avrg: Illumina Body Map 2 (GSE30611)
Navigation
Downloads
Results for ZNF652
Z-value: 1.79
Motif logo
Transcription factors associated with ZNF652
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ZNF652
|
ENSG00000198740.9 | ZNF652 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ZNF652 | hg38_v1_chr17_-_49362206_49362279 | 0.26 | 1.6e-01 | Click! |
Activity profile of ZNF652 motif
Sorted Z-values of ZNF652 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of ZNF652
| Promoter | Score | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chrX_+_103776831 | 4.12 |
ENST00000621218.5
ENST00000619236.1 |
PLP1
|
proteolipid protein 1 |
| chr4_-_89836213 | 3.32 |
ENST00000618500.4
ENST00000508895.5 |
SNCA
|
synuclein alpha |
| chr6_-_6004040 | 2.72 |
ENST00000622188.4
|
NRN1
|
neuritin 1 |
| chr1_+_86468902 | 2.66 |
ENST00000394711.2
|
CLCA1
|
chloride channel accessory 1 |
| chr9_-_115091018 | 2.52 |
ENST00000542877.5
ENST00000537320.5 ENST00000341037.8 |
TNC
|
tenascin C |
| chr4_-_89835617 | 2.34 |
ENST00000611107.1
ENST00000345009.8 ENST00000505199.5 ENST00000502987.5 |
SNCA
|
synuclein alpha |
| chr11_-_119423162 | 2.30 |
ENST00000284240.10
ENST00000524970.5 |
THY1
|
Thy-1 cell surface antigen |
| chr11_-_35525603 | 2.29 |
ENST00000529303.1
ENST00000619888.5 ENST00000622144.4 |
PAMR1
|
peptidase domain containing associated with muscle regeneration 1 |
| chr17_-_10838075 | 2.22 |
ENST00000580256.3
ENST00000643787.1 |
PIRT
ENSG00000284876.1
|
phosphoinositide interacting regulator of transient receptor potential channels novel transcript |
| chr19_+_11538767 | 2.19 |
ENST00000592923.5
ENST00000535659.6 |
CNN1
|
calponin 1 |
| chr10_-_15371225 | 2.17 |
ENST00000378116.9
|
FAM171A1
|
family with sequence similarity 171 member A1 |
| chr3_+_50269140 | 2.16 |
ENST00000616701.5
ENST00000433753.4 ENST00000611067.4 |
SEMA3B
|
semaphorin 3B |
| chr3_-_112641292 | 2.15 |
ENST00000439685.6
|
CCDC80
|
coiled-coil domain containing 80 |
| chr11_-_111911759 | 2.14 |
ENST00000650687.2
|
CRYAB
|
crystallin alpha B |
| chr3_+_157436842 | 2.11 |
ENST00000295927.4
|
PTX3
|
pentraxin 3 |
| chr6_-_34556319 | 1.99 |
ENST00000374037.8
ENST00000544425.2 |
SPDEF
|
SAM pointed domain containing ETS transcription factor |
| chr11_-_119423193 | 1.94 |
ENST00000580275.5
|
THY1
|
Thy-1 cell surface antigen |
| chr19_+_11538844 | 1.94 |
ENST00000252456.7
|
CNN1
|
calponin 1 |
| chr9_+_72149424 | 1.87 |
ENST00000358399.8
ENST00000376986.5 |
GDA
|
guanine deaminase |
| chr7_+_23246697 | 1.86 |
ENST00000381990.6
ENST00000409458.3 ENST00000647578.1 ENST00000258733.9 |
GPNMB
|
glycoprotein nmb |
| chr11_-_35525729 | 1.84 |
ENST00000527605.5
|
PAMR1
|
peptidase domain containing associated with muscle regeneration 1 |
| chrX_-_129654946 | 1.83 |
ENST00000429967.3
|
APLN
|
apelin |
| chr11_-_35526024 | 1.79 |
ENST00000615849.4
|
PAMR1
|
peptidase domain containing associated with muscle regeneration 1 |
| chr1_-_203351115 | 1.77 |
ENST00000354955.5
|
FMOD
|
fibromodulin |
| chr7_-_140640776 | 1.77 |
ENST00000275884.10
ENST00000475837.1 ENST00000496613.6 |
DENND2A
|
DENN domain containing 2A |
| chr19_-_50968775 | 1.73 |
ENST00000391808.5
|
KLK6
|
kallikrein related peptidase 6 |
| chr19_+_55283982 | 1.71 |
ENST00000309383.6
|
BRSK1
|
BR serine/threonine kinase 1 |
| chr1_-_156705764 | 1.70 |
ENST00000621784.4
ENST00000368220.1 |
CRABP2
|
cellular retinoic acid binding protein 2 |
| chr4_+_80197493 | 1.67 |
ENST00000415738.3
|
PRDM8
|
PR/SET domain 8 |
| chr16_+_56589521 | 1.65 |
ENST00000200691.5
ENST00000570176.1 |
MT3
|
metallothionein 3 |
| chr2_-_219309484 | 1.64 |
ENST00000409251.7
ENST00000451506.5 ENST00000446182.5 |
PTPRN
|
protein tyrosine phosphatase receptor type N |
| chr8_-_23404076 | 1.61 |
ENST00000524168.1
ENST00000389131.8 ENST00000523833.2 ENST00000519243.1 |
LOXL2
|
lysyl oxidase like 2 |
| chr3_-_112641128 | 1.61 |
ENST00000206423.8
|
CCDC80
|
coiled-coil domain containing 80 |
| chr5_+_126423176 | 1.60 |
ENST00000542322.5
ENST00000544396.5 |
GRAMD2B
|
GRAM domain containing 2B |
| chr4_-_70666961 | 1.56 |
ENST00000510437.5
|
JCHAIN
|
joining chain of multimeric IgA and IgM |
| chr1_-_156677400 | 1.55 |
ENST00000368223.4
|
NES
|
nestin |
| chr14_-_21536928 | 1.52 |
ENST00000613414.4
|
SALL2
|
spalt like transcription factor 2 |
| chr8_-_109644766 | 1.50 |
ENST00000533065.5
ENST00000276646.14 |
SYBU
|
syntabulin |
| chr9_+_72149351 | 1.49 |
ENST00000238018.8
|
GDA
|
guanine deaminase |
| chr1_+_100719734 | 1.48 |
ENST00000370119.8
ENST00000294728.7 ENST00000347652.6 ENST00000370115.1 |
VCAM1
|
vascular cell adhesion molecule 1 |
| chr4_-_70666492 | 1.47 |
ENST00000254801.9
ENST00000391614.7 |
JCHAIN
|
joining chain of multimeric IgA and IgM |
| chr11_-_35360050 | 1.46 |
ENST00000644868.1
ENST00000643454.1 ENST00000646080.1 |
SLC1A2
|
solute carrier family 1 member 2 |
| chr11_-_82733850 | 1.44 |
ENST00000329203.5
|
FAM181B
|
family with sequence similarity 181 member B |
| chr6_-_131000722 | 1.43 |
ENST00000528282.5
|
EPB41L2
|
erythrocyte membrane protein band 4.1 like 2 |
| chr6_+_99521027 | 1.42 |
ENST00000452647.3
ENST00000636394.1 |
TSTD3
|
thiosulfate sulfurtransferase like domain containing 3 |
| chr1_+_201739864 | 1.41 |
ENST00000367295.5
|
NAV1
|
neuron navigator 1 |
| chr5_+_126423363 | 1.41 |
ENST00000285689.8
|
GRAMD2B
|
GRAM domain containing 2B |
| chr14_+_79279906 | 1.38 |
ENST00000428277.6
|
NRXN3
|
neurexin 3 |
| chr2_-_68319887 | 1.36 |
ENST00000409862.1
ENST00000263655.4 |
CNRIP1
|
cannabinoid receptor interacting protein 1 |
| chr2_+_203328266 | 1.36 |
ENST00000261017.9
|
ABI2
|
abl interactor 2 |
| chr2_-_189179754 | 1.34 |
ENST00000374866.9
ENST00000618828.1 |
COL5A2
|
collagen type V alpha 2 chain |
| chr14_-_21537206 | 1.33 |
ENST00000614342.1
|
SALL2
|
spalt like transcription factor 2 |
| chr17_+_50532713 | 1.32 |
ENST00000503690.5
ENST00000514874.5 ENST00000268933.8 |
EPN3
|
epsin 3 |
| chr1_+_162631984 | 1.31 |
ENST00000415555.5
|
DDR2
|
discoidin domain receptor tyrosine kinase 2 |
| chr3_-_98517096 | 1.30 |
ENST00000513873.1
|
CLDND1
|
claudin domain containing 1 |
| chr22_-_24245059 | 1.30 |
ENST00000398292.3
ENST00000263112.11 ENST00000327365.10 ENST00000424217.1 |
GGT5
|
gamma-glutamyltransferase 5 |
| chr9_+_128411715 | 1.29 |
ENST00000420034.5
ENST00000372842.5 |
CERCAM
|
cerebral endothelial cell adhesion molecule |
| chr17_-_7205116 | 1.29 |
ENST00000649520.1
ENST00000649186.1 |
DLG4
|
discs large MAGUK scaffold protein 4 |
| chr16_-_57284654 | 1.27 |
ENST00000613167.4
ENST00000219207.10 ENST00000569059.5 |
PLLP
|
plasmolipin |
| chr5_+_126423122 | 1.27 |
ENST00000515200.5
|
GRAMD2B
|
GRAM domain containing 2B |
| chrX_-_153830527 | 1.27 |
ENST00000393758.7
ENST00000544474.5 |
PDZD4
|
PDZ domain containing 4 |
| chr3_-_73561608 | 1.26 |
ENST00000466780.5
|
PDZRN3
|
PDZ domain containing ring finger 3 |
| chr11_-_130428605 | 1.26 |
ENST00000257359.7
|
ADAMTS8
|
ADAM metallopeptidase with thrombospondin type 1 motif 8 |
| chr7_-_140641450 | 1.25 |
ENST00000491728.5
|
DENND2A
|
DENN domain containing 2A |
| chr4_-_70666884 | 1.25 |
ENST00000510614.5
|
JCHAIN
|
joining chain of multimeric IgA and IgM |
| chr21_-_26843063 | 1.24 |
ENST00000678221.1
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif 1 |
| chr5_-_154478218 | 1.24 |
ENST00000231121.3
|
HAND1
|
heart and neural crest derivatives expressed 1 |
| chr21_-_26843012 | 1.23 |
ENST00000517777.6
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif 1 |
| chr20_-_3173516 | 1.21 |
ENST00000360342.7
ENST00000645462.1 ENST00000337576.7 |
LZTS3
|
leucine zipper tumor suppressor family member 3 |
| chr1_+_26021768 | 1.21 |
ENST00000374280.4
|
EXTL1
|
exostosin like glycosyltransferase 1 |
| chr19_-_14206168 | 1.18 |
ENST00000361434.7
ENST00000340736.10 |
ADGRL1
|
adhesion G protein-coupled receptor L1 |
| chr1_-_150808251 | 1.18 |
ENST00000271651.8
ENST00000676970.1 ENST00000679260.1 ENST00000676751.1 ENST00000677887.1 |
CTSK
|
cathepsin K |
| chr5_+_140125935 | 1.17 |
ENST00000333305.5
|
IGIP
|
IgA inducing protein |
| chr5_-_60844262 | 1.15 |
ENST00000508821.6
ENST00000507047.5 ENST00000425382.5 |
ELOVL7
|
ELOVL fatty acid elongase 7 |
| chrX_+_52897306 | 1.13 |
ENST00000612188.4
ENST00000616419.4 ENST00000416841.7 ENST00000593751.7 |
FAM156B
|
family with sequence similarity 156 member B |
| chr4_-_110198579 | 1.13 |
ENST00000302274.8
|
ELOVL6
|
ELOVL fatty acid elongase 6 |
| chr3_-_149333619 | 1.12 |
ENST00000296059.7
|
TM4SF18
|
transmembrane 4 L six family member 18 |
| chr2_+_10911924 | 1.12 |
ENST00000295082.3
|
KCNF1
|
potassium voltage-gated channel modifier subfamily F member 1 |
| chr16_+_31472130 | 1.11 |
ENST00000394863.8
ENST00000565360.5 ENST00000361773.7 |
TGFB1I1
|
transforming growth factor beta 1 induced transcript 1 |
| chr10_-_15371044 | 1.09 |
ENST00000455654.1
|
FAM171A1
|
family with sequence similarity 171 member A1 |
| chr2_-_240820945 | 1.08 |
ENST00000428768.2
ENST00000650053.1 ENST00000650130.1 |
KIF1A
|
kinesin family member 1A |
| chr11_-_89491320 | 1.08 |
ENST00000534731.5
ENST00000527626.5 ENST00000525196.5 ENST00000263317.9 |
NOX4
|
NADPH oxidase 4 |
| chr2_+_39665902 | 1.08 |
ENST00000281961.3
ENST00000618232.1 |
TMEM178A
|
transmembrane protein 178A |
| chr5_-_176630517 | 1.07 |
ENST00000393693.7
ENST00000614675.4 |
SNCB
|
synuclein beta |
| chr17_-_47957824 | 1.07 |
ENST00000300557.3
|
PRR15L
|
proline rich 15 like |
| chr4_-_98657635 | 1.06 |
ENST00000515287.5
ENST00000511651.5 ENST00000505184.5 |
TSPAN5
|
tetraspanin 5 |
| chr17_-_44830774 | 1.05 |
ENST00000590758.3
ENST00000591424.5 |
GJC1
|
gap junction protein gamma 1 |
| chr14_-_21536884 | 1.03 |
ENST00000546363.5
|
SALL2
|
spalt like transcription factor 2 |
| chr7_-_30026617 | 1.03 |
ENST00000222803.10
|
FKBP14
|
FKBP prolyl isomerase 14 |
| chr2_-_201642653 | 1.01 |
ENST00000621467.4
|
TMEM237
|
transmembrane protein 237 |
| chr5_+_162067458 | 0.97 |
ENST00000639975.1
ENST00000639111.2 ENST00000639683.1 |
GABRG2
|
gamma-aminobutyric acid type A receptor subunit gamma2 |
| chr2_-_219309350 | 0.97 |
ENST00000295718.7
|
PTPRN
|
protein tyrosine phosphatase receptor type N |
| chr17_+_45148468 | 0.95 |
ENST00000332499.4
|
HEXIM1
|
HEXIM P-TEFb complex subunit 1 |
| chr6_-_53348902 | 0.94 |
ENST00000370913.5
ENST00000304434.11 |
ELOVL5
|
ELOVL fatty acid elongase 5 |
| chr17_-_19387170 | 0.94 |
ENST00000395592.6
ENST00000299610.5 |
MFAP4
|
microfibril associated protein 4 |
| chr17_+_12665882 | 0.94 |
ENST00000425538.6
|
MYOCD
|
myocardin |
| chr12_-_56688156 | 0.94 |
ENST00000436399.6
|
PTGES3
|
prostaglandin E synthase 3 |
| chrX_-_153830490 | 0.93 |
ENST00000164640.8
|
PDZD4
|
PDZ domain containing 4 |
| chr20_-_62367304 | 0.93 |
ENST00000252999.7
|
LAMA5
|
laminin subunit alpha 5 |
| chr17_-_19386785 | 0.93 |
ENST00000497081.6
|
MFAP4
|
microfibril associated protein 4 |
| chr11_-_86672114 | 0.92 |
ENST00000393324.7
|
ME3
|
malic enzyme 3 |
| chr17_+_28473278 | 0.91 |
ENST00000444914.7
|
SLC13A2
|
solute carrier family 13 member 2 |
| chr17_+_49576091 | 0.89 |
ENST00000513748.1
|
NXPH3
|
neurexophilin 3 |
| chr19_+_41219235 | 0.89 |
ENST00000359092.7
|
AXL
|
AXL receptor tyrosine kinase |
| chr2_-_89143133 | 0.88 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
| chr2_+_43774033 | 0.87 |
ENST00000260605.12
ENST00000406852.7 ENST00000398823.6 ENST00000605786.5 |
DYNC2LI1
|
dynein cytoplasmic 2 light intermediate chain 1 |
| chr5_+_162067500 | 0.87 |
ENST00000639384.1
ENST00000640985.1 ENST00000638772.1 |
GABRG2
|
gamma-aminobutyric acid type A receptor subunit gamma2 |
| chr12_-_119803383 | 0.85 |
ENST00000392520.2
ENST00000678677.1 ENST00000679249.1 ENST00000676849.1 |
CIT
|
citron rho-interacting serine/threonine kinase |
| chr6_+_39792993 | 0.85 |
ENST00000538976.5
|
DAAM2
|
dishevelled associated activator of morphogenesis 2 |
| chr17_+_28473635 | 0.85 |
ENST00000314669.10
ENST00000545060.2 |
SLC13A2
|
solute carrier family 13 member 2 |
| chr6_+_39793008 | 0.85 |
ENST00000398904.6
|
DAAM2
|
dishevelled associated activator of morphogenesis 2 |
| chr11_+_107591222 | 0.84 |
ENST00000443271.2
|
ELMOD1
|
ELMO domain containing 1 |
| chr10_-_99235846 | 0.84 |
ENST00000370552.8
ENST00000370549.5 ENST00000628193.2 |
HPSE2
|
heparanase 2 (inactive) |
| chr4_-_7871986 | 0.84 |
ENST00000360265.9
|
AFAP1
|
actin filament associated protein 1 |
| chr12_-_6700788 | 0.83 |
ENST00000320591.9
ENST00000534837.6 |
PIANP
|
PILR alpha associated neural protein |
| chr2_-_217944005 | 0.83 |
ENST00000611415.4
ENST00000615025.5 ENST00000449814.1 ENST00000171887.8 |
TNS1
|
tensin 1 |
| chr6_+_125781108 | 0.83 |
ENST00000368357.7
|
NCOA7
|
nuclear receptor coactivator 7 |
| chr11_-_63614425 | 0.82 |
ENST00000415826.3
|
PLAAT3
|
phospholipase A and acyltransferase 3 |
| chr10_-_13972355 | 0.82 |
ENST00000264546.10
|
FRMD4A
|
FERM domain containing 4A |
| chr5_+_140821598 | 0.81 |
ENST00000614258.1
ENST00000529859.2 ENST00000529619.5 |
PCDHA5
|
protocadherin alpha 5 |
| chr2_+_137964446 | 0.81 |
ENST00000280096.5
ENST00000280097.5 |
HNMT
|
histamine N-methyltransferase |
| chr11_-_86672419 | 0.81 |
ENST00000524826.7
ENST00000532471.1 |
ME3
|
malic enzyme 3 |
| chr3_+_194136138 | 0.80 |
ENST00000232424.4
|
HES1
|
hes family bHLH transcription factor 1 |
| chr13_-_37598750 | 0.80 |
ENST00000379743.8
ENST00000379742.4 ENST00000379749.8 ENST00000379747.9 ENST00000541179.5 ENST00000541481.5 |
POSTN
|
periostin |
| chr5_-_11588842 | 0.80 |
ENST00000503622.5
|
CTNND2
|
catenin delta 2 |
| chr5_-_60844185 | 0.79 |
ENST00000505959.5
|
ELOVL7
|
ELOVL fatty acid elongase 7 |
| chr5_+_162067764 | 0.79 |
ENST00000639213.2
ENST00000414552.6 |
GABRG2
|
gamma-aminobutyric acid type A receptor subunit gamma2 |
| chr13_+_110615516 | 0.79 |
ENST00000680254.1
ENST00000424185.7 ENST00000679389.1 |
NAXD
|
NAD(P)HX dehydratase |
| chr11_+_107591077 | 0.78 |
ENST00000531234.5
ENST00000265840.12 |
ELMOD1
|
ELMO domain containing 1 |
| chr4_-_185810894 | 0.78 |
ENST00000448662.6
ENST00000439049.5 ENST00000420158.5 ENST00000319471.13 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr19_+_37506931 | 0.77 |
ENST00000627814.3
ENST00000587143.5 |
ZNF793
|
zinc finger protein 793 |
| chr3_+_138621207 | 0.76 |
ENST00000464668.5
|
FAIM
|
Fas apoptotic inhibitory molecule |
| chr17_-_47851155 | 0.76 |
ENST00000536300.2
|
SP6
|
Sp6 transcription factor |
| chr12_-_123272234 | 0.76 |
ENST00000544658.5
|
CDK2AP1
|
cyclin dependent kinase 2 associated protein 1 |
| chr14_-_106422175 | 0.75 |
ENST00000390619.2
|
IGHV4-39
|
immunoglobulin heavy variable 4-39 |
| chr1_+_215573775 | 0.75 |
ENST00000448333.1
|
KCTD3
|
potassium channel tetramerization domain containing 3 |
| chr11_-_129024157 | 0.73 |
ENST00000392657.7
|
ARHGAP32
|
Rho GTPase activating protein 32 |
| chr3_-_64445396 | 0.73 |
ENST00000295902.11
|
PRICKLE2
|
prickle planar cell polarity protein 2 |
| chr14_+_79279403 | 0.72 |
ENST00000281127.11
|
NRXN3
|
neurexin 3 |
| chr14_+_79280056 | 0.72 |
ENST00000676811.1
|
NRXN3
|
neurexin 3 |
| chr3_-_149333407 | 0.72 |
ENST00000470080.5
|
TM4SF18
|
transmembrane 4 L six family member 18 |
| chr3_-_127722562 | 0.71 |
ENST00000487473.5
ENST00000484451.1 |
MGLL
|
monoglyceride lipase |
| chr12_-_123271803 | 0.71 |
ENST00000261692.7
|
CDK2AP1
|
cyclin dependent kinase 2 associated protein 1 |
| chr2_-_68319398 | 0.71 |
ENST00000409559.7
|
CNRIP1
|
cannabinoid receptor interacting protein 1 |
| chr7_-_150978284 | 0.70 |
ENST00000262186.10
|
KCNH2
|
potassium voltage-gated channel subfamily H member 2 |
| chr6_+_44270434 | 0.70 |
ENST00000451188.7
|
TMEM151B
|
transmembrane protein 151B |
| chr9_+_128098304 | 0.70 |
ENST00000373064.9
|
SLC25A25
|
solute carrier family 25 member 25 |
| chr7_+_12687625 | 0.70 |
ENST00000651779.1
ENST00000404894.1 |
ARL4A
|
ADP ribosylation factor like GTPase 4A |
| chr2_+_171522227 | 0.69 |
ENST00000409484.5
|
CYBRD1
|
cytochrome b reductase 1 |
| chr5_-_176630364 | 0.69 |
ENST00000310112.7
|
SNCB
|
synuclein beta |
| chr20_-_50636887 | 0.69 |
ENST00000045083.6
|
RIPOR3
|
RIPOR family member 3 |
| chr1_+_26159071 | 0.68 |
ENST00000374268.5
|
FAM110D
|
family with sequence similarity 110 member D |
| chr18_+_35041387 | 0.68 |
ENST00000538170.6
ENST00000300249.10 ENST00000588910.5 |
MAPRE2
|
microtubule associated protein RP/EB family member 2 |
| chr1_+_179025804 | 0.68 |
ENST00000440702.5
|
FAM20B
|
FAM20B glycosaminoglycan xylosylkinase |
| chr12_+_112575027 | 0.68 |
ENST00000547686.5
ENST00000543106.6 ENST00000551593.5 ENST00000546426.5 ENST00000551748.5 ENST00000546703.5 |
RPH3A
|
rabphilin 3A |
| chr1_+_162631946 | 0.68 |
ENST00000671979.1
|
DDR2
|
discoidin domain receptor tyrosine kinase 2 |
| chrX_-_103688033 | 0.68 |
ENST00000434230.5
ENST00000418819.5 ENST00000360458.5 |
MORF4L2
|
mortality factor 4 like 2 |
| chr20_+_8649391 | 0.67 |
ENST00000475958.1
|
PLCB1
|
phospholipase C beta 1 |
| chr4_-_110198650 | 0.66 |
ENST00000394607.7
|
ELOVL6
|
ELOVL fatty acid elongase 6 |
| chrX_-_103688090 | 0.66 |
ENST00000433176.6
|
MORF4L2
|
mortality factor 4 like 2 |
| chr12_+_20695442 | 0.66 |
ENST00000540354.5
|
SLCO1C1
|
solute carrier organic anion transporter family member 1C1 |
| chr17_-_1125715 | 0.65 |
ENST00000574437.5
|
ABR
|
ABR activator of RhoGEF and GTPase |
| chr8_-_17697654 | 0.65 |
ENST00000297488.10
|
MTUS1
|
microtubule associated scaffold protein 1 |
| chr12_+_20695469 | 0.65 |
ENST00000545604.5
|
SLCO1C1
|
solute carrier organic anion transporter family member 1C1 |
| chr17_-_1126531 | 0.65 |
ENST00000570525.5
|
ABR
|
ABR activator of RhoGEF and GTPase |
| chr11_-_119095456 | 0.65 |
ENST00000530167.1
|
H2AX
|
H2A.X variant histone |
| chr13_+_110615622 | 0.64 |
ENST00000309957.3
ENST00000680505.1 |
NAXD
|
NAD(P)HX dehydratase |
| chr17_+_50532681 | 0.64 |
ENST00000503246.1
|
EPN3
|
epsin 3 |
| chr8_-_140764386 | 0.63 |
ENST00000520151.5
ENST00000519024.5 ENST00000519465.5 |
PTK2
|
protein tyrosine kinase 2 |
| chr8_+_1973668 | 0.63 |
ENST00000320248.4
|
KBTBD11
|
kelch repeat and BTB domain containing 11 |
| chr11_-_63614366 | 0.63 |
ENST00000323646.9
|
PLAAT3
|
phospholipase A and acyltransferase 3 |
| chr11_+_73264479 | 0.62 |
ENST00000393592.7
ENST00000540342.6 ENST00000679753.1 ENST00000542092.5 ENST00000349767.6 |
P2RY6
|
pyrimidinergic receptor P2Y6 |
| chr11_-_62984957 | 0.62 |
ENST00000377871.7
ENST00000360421.9 |
SLC22A6
|
solute carrier family 22 member 6 |
| chr11_-_89491131 | 0.62 |
ENST00000343727.9
ENST00000531342.5 ENST00000375979.7 |
NOX4
|
NADPH oxidase 4 |
| chr17_-_9959455 | 0.62 |
ENST00000580865.5
ENST00000583882.5 |
GAS7
|
growth arrest specific 7 |
| chr15_-_79090760 | 0.61 |
ENST00000419573.7
ENST00000558480.7 |
RASGRF1
|
Ras protein specific guanine nucleotide releasing factor 1 |
| chr1_+_179025886 | 0.61 |
ENST00000263733.5
|
FAM20B
|
FAM20B glycosaminoglycan xylosylkinase |
| chr6_-_31729785 | 0.61 |
ENST00000416410.6
|
DDAH2
|
dimethylarginine dimethylaminohydrolase 2 |
| chr2_+_171522466 | 0.61 |
ENST00000321348.9
ENST00000375252.3 |
CYBRD1
|
cytochrome b reductase 1 |
| chr22_+_38213530 | 0.61 |
ENST00000407965.1
|
MAFF
|
MAF bZIP transcription factor F |
| chr8_-_100950549 | 0.60 |
ENST00000395951.7
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta |
| chr8_+_28494190 | 0.60 |
ENST00000537916.2
ENST00000240093.8 ENST00000523546.1 |
FZD3
|
frizzled class receptor 3 |
| chr15_+_73684204 | 0.60 |
ENST00000537340.6
ENST00000318424.9 |
CD276
|
CD276 molecule |
| chr11_-_72112669 | 0.60 |
ENST00000545944.5
ENST00000502597.2 |
ANAPC15
|
anaphase promoting complex subunit 15 |
| chr7_+_101362835 | 0.59 |
ENST00000313669.12
ENST00000613501.1 |
COL26A1
|
collagen type XXVI alpha 1 chain |
| chr1_+_2467437 | 0.59 |
ENST00000449969.5
|
PLCH2
|
phospholipase C eta 2 |
| chr17_-_7479616 | 0.59 |
ENST00000380599.9
|
ZBTB4
|
zinc finger and BTB domain containing 4 |
| chr1_+_215082731 | 0.59 |
ENST00000444842.7
|
KCNK2
|
potassium two pore domain channel subfamily K member 2 |
| chr12_+_20695553 | 0.58 |
ENST00000545102.1
|
SLCO1C1
|
solute carrier organic anion transporter family member 1C1 |
| chr9_+_128922283 | 0.57 |
ENST00000421063.6
|
PHYHD1
|
phytanoyl-CoA dioxygenase domain containing 1 |
| chr6_+_70566892 | 0.57 |
ENST00000370474.4
|
SDHAF4
|
succinate dehydrogenase complex assembly factor 4 |
| chr14_+_79279681 | 0.57 |
ENST00000679122.1
|
NRXN3
|
neurexin 3 |
| chr9_+_128921748 | 0.56 |
ENST00000426694.5
|
PHYHD1
|
phytanoyl-CoA dioxygenase domain containing 1 |
| chr5_-_112419251 | 0.56 |
ENST00000261486.6
|
EPB41L4A
|
erythrocyte membrane protein band 4.1 like 4A |
| chr2_-_2324323 | 0.56 |
ENST00000648339.1
ENST00000647694.1 |
MYT1L
|
myelin transcription factor 1 like |
| chr14_-_21537064 | 0.55 |
ENST00000541965.1
|
SALL2
|
spalt like transcription factor 2 |
| chr3_+_138621225 | 0.55 |
ENST00000479848.1
|
FAIM
|
Fas apoptotic inhibitory molecule |
| chr11_-_86672328 | 0.55 |
ENST00000526834.1
ENST00000323418.10 |
ME3
|
malic enzyme 3 |
| chr1_+_35558506 | 0.55 |
ENST00000437806.1
|
NCDN
|
neurochondrin |
| chr3_+_159273235 | 0.54 |
ENST00000638749.1
|
IQCJ-SCHIP1
|
IQCJ-SCHIP1 readthrough |
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.1 | 3.4 | GO:0006147 | guanine catabolic process(GO:0006147) |
| 1.1 | 4.2 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.9 | 5.7 | GO:0051621 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
| 0.9 | 2.6 | GO:1904692 | positive regulation of type B pancreatic cell proliferation(GO:1904692) |
| 0.8 | 2.5 | GO:0060739 | mesenchymal-epithelial cell signaling involved in prostate gland development(GO:0060739) |
| 0.6 | 1.8 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
| 0.6 | 1.8 | GO:1903015 | regulation of exo-alpha-sialidase activity(GO:1903015) |
| 0.5 | 1.6 | GO:0097212 | lysosomal membrane organization(GO:0097212) negative regulation of hydrogen peroxide catabolic process(GO:2000296) regulation of oxygen metabolic process(GO:2000374) |
| 0.5 | 1.9 | GO:2000724 | positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
| 0.4 | 1.2 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
| 0.4 | 1.6 | GO:0018277 | protein deamination(GO:0018277) |
| 0.4 | 2.0 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
| 0.4 | 4.3 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.4 | 5.4 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.4 | 1.8 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.3 | 1.3 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.3 | 0.8 | GO:0045608 | auditory receptor cell fate determination(GO:0042668) negative regulation of auditory receptor cell differentiation(GO:0045608) negative regulation of pro-B cell differentiation(GO:2000974) |
| 0.3 | 2.3 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.2 | 0.7 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) negative regulation of potassium ion export(GO:1902303) |
| 0.2 | 0.7 | GO:2000559 | CD24 biosynthetic process(GO:0035724) activation of meiosis involved in egg activation(GO:0060466) negative regulation of monocyte extravasation(GO:2000438) regulation of CD24 biosynthetic process(GO:2000559) positive regulation of CD24 biosynthetic process(GO:2000560) |
| 0.2 | 1.5 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 0.2 | 1.1 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.2 | 4.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.2 | 1.3 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) negative regulation of dendritic cell apoptotic process(GO:2000669) |
| 0.2 | 4.1 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.2 | 1.0 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.2 | 0.8 | GO:0032571 | response to vitamin K(GO:0032571) bone regeneration(GO:1990523) |
| 0.2 | 1.8 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.1 | 0.4 | GO:1901877 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.1 | 1.3 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
| 0.1 | 1.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.1 | 2.4 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
| 0.1 | 1.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 | 0.8 | GO:0001692 | histamine metabolic process(GO:0001692) |
| 0.1 | 0.9 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
| 0.1 | 5.1 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
| 0.1 | 1.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.1 | 0.4 | GO:1990051 | activation of protein kinase C activity(GO:1990051) |
| 0.1 | 0.6 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
| 0.1 | 0.6 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.1 | 2.3 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.1 | 0.3 | GO:0032824 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) positive regulation of cytolysis in other organism(GO:0051714) |
| 0.1 | 2.0 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) |
| 0.1 | 3.0 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.1 | 0.4 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.1 | 2.3 | GO:0000052 | citrulline metabolic process(GO:0000052) |
| 0.1 | 0.5 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.1 | 0.4 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.1 | 2.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.1 | 1.5 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.1 | 0.9 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.1 | 0.4 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 | 1.7 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.1 | 2.5 | GO:0060347 | heart trabecula formation(GO:0060347) |
| 0.1 | 0.9 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 | 0.4 | GO:0072144 | glomerular mesangial cell development(GO:0072144) |
| 0.1 | 0.2 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
| 0.1 | 1.3 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.1 | 0.7 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.1 | 0.8 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.1 | 1.4 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.1 | 0.5 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.1 | 1.0 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.1 | 0.4 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.1 | 1.3 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.1 | 0.2 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.1 | 2.2 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.1 | 0.2 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
| 0.1 | 0.2 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.1 | 0.5 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.1 | 1.4 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.1 | 0.9 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 | 0.9 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
| 0.1 | 0.3 | GO:0001757 | somite specification(GO:0001757) |
| 0.1 | 0.5 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.0 | 0.7 | GO:0015866 | ADP transport(GO:0015866) |
| 0.0 | 1.6 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
| 0.0 | 0.1 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
| 0.0 | 1.4 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.0 | 1.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.0 | 0.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.0 | 0.2 | GO:1901073 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 0.0 | 1.1 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.0 | 0.5 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.0 | 1.9 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
| 0.0 | 0.2 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
| 0.0 | 0.3 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.0 | 0.2 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.0 | 1.4 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
| 0.0 | 1.0 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
| 0.0 | 0.4 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
| 0.0 | 0.2 | GO:0019075 | virus maturation(GO:0019075) |
| 0.0 | 1.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.0 | 0.2 | GO:0071335 | submandibular salivary gland formation(GO:0060661) hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 0.0 | 1.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 | 0.2 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.0 | 0.2 | GO:0097403 | cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
| 0.0 | 0.6 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.0 | 0.4 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.0 | 0.1 | GO:0009085 | lysine biosynthetic process(GO:0009085) lysine biosynthetic process via aminoadipic acid(GO:0019878) |
| 0.0 | 0.6 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
| 0.0 | 0.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 | 0.4 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.0 | 0.3 | GO:2000002 | negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
| 0.0 | 0.7 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.0 | 0.1 | GO:0071676 | negative regulation of mononuclear cell migration(GO:0071676) |
| 0.0 | 0.5 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.0 | 1.8 | GO:0042417 | dopamine metabolic process(GO:0042417) |
| 0.0 | 0.5 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.0 | 0.8 | GO:0003094 | glomerular filtration(GO:0003094) |
| 0.0 | 0.3 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
| 0.0 | 2.2 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.0 | 0.1 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.0 | 0.6 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.0 | 1.7 | GO:0014003 | oligodendrocyte development(GO:0014003) |
| 0.0 | 1.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.0 | 0.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.0 | 0.9 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
| 0.0 | 0.6 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.0 | 0.6 | GO:0007567 | parturition(GO:0007567) |
| 0.0 | 1.3 | GO:0010039 | response to iron ion(GO:0010039) |
| 0.0 | 0.6 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.0 | 0.4 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.0 | 0.2 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.0 | 3.2 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 | 0.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.0 | 0.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.0 | 0.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.0 | 1.0 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.0 | 0.6 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.0 | 1.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 0.0 | 0.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.0 | 0.4 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.0 | 1.5 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
| 0.0 | 0.2 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.0 | 0.6 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 0.0 | 2.7 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.0 | 0.4 | GO:0060074 | synapse maturation(GO:0060074) |
| 0.0 | 0.4 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) |
| 0.0 | 0.2 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
| 0.0 | 2.3 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.0 | 0.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.0 | 1.4 | GO:0007528 | neuromuscular junction development(GO:0007528) |
| 0.0 | 0.6 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
| 0.0 | 0.1 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 0.0 | 0.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.0 | 0.5 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
| 0.0 | 3.7 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.0 | 0.0 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.0 | 1.0 | GO:0008089 | anterograde axonal transport(GO:0008089) |
| 0.0 | 0.4 | GO:0009437 | carnitine metabolic process(GO:0009437) |
| 0.0 | 2.3 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.0 | 0.6 | GO:0030033 | microvillus assembly(GO:0030033) |
| 0.0 | 1.0 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 | 0.1 | GO:0003245 | growth involved in heart morphogenesis(GO:0003241) cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.0 | 0.2 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.0 | 0.2 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
| 0.0 | 0.2 | GO:0097324 | melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.0 | 0.6 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
| 0.0 | 1.1 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
| 0.0 | 0.1 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.0 | 0.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 | 1.2 | GO:0006835 | dicarboxylic acid transport(GO:0006835) |
| 0.0 | 0.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.0 | 0.4 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 | 0.7 | GO:0010761 | fibroblast migration(GO:0010761) |
| 0.0 | 0.2 | GO:1902884 | positive regulation of response to oxidative stress(GO:1902884) |
| 0.0 | 0.5 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.0 | 0.5 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 | 0.8 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.1 | 4.3 | GO:0071757 | hexameric IgM immunoglobulin complex(GO:0071757) |
| 0.9 | 0.9 | GO:0071754 | IgM immunoglobulin complex(GO:0071753) IgM immunoglobulin complex, circulating(GO:0071754) pentameric IgM immunoglobulin complex(GO:0071756) |
| 0.5 | 1.5 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 0.3 | 1.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.3 | 0.9 | GO:0043260 | laminin-10 complex(GO:0043259) laminin-11 complex(GO:0043260) |
| 0.2 | 1.9 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.2 | 1.2 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.2 | 5.9 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.1 | 0.7 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.1 | 7.9 | GO:0032590 | dendrite membrane(GO:0032590) |
| 0.1 | 2.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.1 | 5.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.1 | 1.8 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.1 | 1.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.1 | 4.3 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.1 | 0.4 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.1 | 1.9 | GO:0008091 | spectrin(GO:0008091) |
| 0.1 | 1.3 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 0.1 | 1.5 | GO:0097433 | dense body(GO:0097433) |
| 0.1 | 1.6 | GO:0097450 | astrocyte end-foot(GO:0097450) |
| 0.1 | 1.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
| 0.1 | 1.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.1 | 0.2 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.1 | 0.2 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.1 | 0.6 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.0 | 1.3 | GO:0033643 | host cell part(GO:0033643) |
| 0.0 | 5.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.0 | 1.7 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.0 | 1.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.0 | 0.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.0 | 1.1 | GO:0005922 | connexon complex(GO:0005922) |
| 0.0 | 1.3 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.0 | 0.6 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.0 | 0.2 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
| 0.0 | 1.3 | GO:0043218 | compact myelin(GO:0043218) |
| 0.0 | 0.3 | GO:0005687 | U4 snRNP(GO:0005687) |
| 0.0 | 0.9 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.0 | 1.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.0 | 1.1 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.0 | 0.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.0 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.0 | 1.5 | GO:0030673 | axolemma(GO:0030673) |
| 0.0 | 7.4 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.0 | 0.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.0 | 0.5 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
| 0.0 | 2.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.0 | 2.6 | GO:0043679 | axon terminus(GO:0043679) |
| 0.0 | 0.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.0 | 1.5 | GO:0044853 | plasma membrane raft(GO:0044853) |
| 0.0 | 0.9 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.0 | 0.5 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.0 | 1.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.0 | 0.5 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.0 | 0.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.0 | 0.3 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
| 0.0 | 2.6 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.0 | 0.4 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.0 | 0.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.0 | 1.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.0 | 1.2 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.0 | 4.2 | GO:0098793 | presynapse(GO:0098793) |
| 0.0 | 2.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.0 | 9.9 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.0 | 2.8 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
| 0.0 | 0.9 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.0 | 0.0 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.0 | 0.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.0 | 2.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 2.1 | GO:0005912 | adherens junction(GO:0005912) |
| 0.0 | 0.5 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.1 | 3.4 | GO:0008892 | guanine deaminase activity(GO:0008892) |
| 0.9 | 5.7 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
| 0.7 | 2.0 | GO:1990175 | EH domain binding(GO:1990175) |
| 0.6 | 4.3 | GO:0019862 | IgA binding(GO:0019862) |
| 0.5 | 1.0 | GO:0030305 | heparanase activity(GO:0030305) |
| 0.5 | 4.4 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.4 | 4.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.4 | 5.4 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.4 | 1.8 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
| 0.3 | 2.3 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.3 | 1.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
| 0.3 | 1.4 | GO:0016524 | latrotoxin receptor activity(GO:0016524) |
| 0.3 | 5.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.3 | 2.1 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.2 | 2.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.2 | 1.1 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
| 0.2 | 1.2 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
| 0.2 | 1.8 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 0.2 | 1.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.2 | 0.9 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.2 | 1.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
| 0.2 | 5.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.2 | 1.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.2 | 3.0 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.2 | 0.5 | GO:0052857 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 0.1 | 1.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.1 | 1.4 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.1 | 4.9 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.1 | 1.1 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.1 | 2.0 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.1 | 1.4 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.1 | 0.5 | GO:0004556 | alpha-amylase activity(GO:0004556) |
| 0.1 | 1.6 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.1 | 0.4 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 0.1 | 1.5 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.1 | 0.9 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.1 | 0.4 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.1 | 0.8 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 0.1 | 0.3 | GO:0045550 | geranylgeranyl reductase activity(GO:0045550) |
| 0.1 | 0.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.1 | 0.3 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
| 0.1 | 0.6 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 0.1 | 1.7 | GO:0019841 | retinol binding(GO:0019841) |
| 0.1 | 0.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.1 | 2.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.1 | 1.0 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.1 | 1.3 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.1 | 0.2 | GO:0004651 | polynucleotide 5'-phosphatase activity(GO:0004651) |
| 0.1 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.1 | 1.6 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.1 | 0.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.1 | 1.0 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.1 | 0.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.1 | 0.3 | GO:0043273 | CTPase activity(GO:0043273) |
| 0.1 | 0.2 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
| 0.1 | 0.2 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) N-acylmannosamine kinase activity(GO:0009384) |
| 0.1 | 0.4 | GO:0004515 | nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 0.1 | 0.5 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.1 | 0.2 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
| 0.1 | 0.9 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.1 | 1.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.1 | 1.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.1 | 2.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.1 | 2.2 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.1 | 0.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.0 | 0.7 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.0 | 1.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.0 | 0.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.0 | 0.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
| 0.0 | 3.2 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.0 | 0.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.0 | 0.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.0 | 0.4 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.0 | 0.2 | GO:0032427 | GBD domain binding(GO:0032427) |
| 0.0 | 1.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.0 | 0.7 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.0 | 3.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.0 | 0.5 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 0.0 | 0.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.0 | 1.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.0 | 0.5 | GO:0030284 | estrogen receptor activity(GO:0030284) |
| 0.0 | 0.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.0 | 1.8 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.0 | 0.3 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 0.0 | 0.2 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.0 | 0.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.0 | 1.0 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.0 | 2.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.0 | 0.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 0.0 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) ethanolaminephosphotransferase activity(GO:0004307) |
| 0.0 | 1.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.0 | 0.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.0 | 0.6 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
| 0.0 | 0.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.0 | 0.6 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
| 0.0 | 1.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.0 | 0.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.0 | 0.7 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.0 | 1.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
| 0.0 | 0.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.0 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.0 | 0.1 | GO:0004797 | deoxycytidine kinase activity(GO:0004137) thymidine kinase activity(GO:0004797) |
| 0.0 | 0.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.0 | 0.5 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.0 | 0.9 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.0 | 0.1 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.0 | 0.0 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
| 0.0 | 0.8 | GO:0005507 | copper ion binding(GO:0005507) |
| 0.0 | 0.1 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
| 0.0 | 0.2 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
| 0.0 | 0.1 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.1 | 7.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.1 | 4.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.1 | 3.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.1 | 4.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.0 | 0.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.0 | 11.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 0.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.0 | 0.9 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.0 | 3.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
| 0.0 | 0.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.0 | 0.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.0 | 1.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.0 | 1.7 | PID IGF1 PATHWAY | IGF1 pathway |
| 0.0 | 1.9 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.0 | 0.9 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.0 | 2.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.0 | 0.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.0 | 0.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.0 | 1.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.0 | 1.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.0 | 1.4 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.0 | 0.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.0 | 1.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.0 | 1.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.0 | 0.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.0 | 1.0 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
| 0.0 | 0.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.2 | 3.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.1 | 5.4 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.1 | 1.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.1 | 1.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.1 | 1.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.1 | 3.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.1 | 1.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.1 | 3.0 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.0 | 0.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.0 | 1.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.0 | 1.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.0 | 0.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 0.0 | 0.5 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.0 | 1.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.0 | 0.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.0 | 1.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.0 | 1.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.0 | 2.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.0 | 0.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.0 | 1.6 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
| 0.0 | 1.3 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
| 0.0 | 0.6 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.0 | 0.8 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.0 | 0.8 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.0 | 0.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.0 | 0.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 0.0 | 2.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.0 | 0.5 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.0 | 1.7 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
| 0.0 | 0.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.0 | 0.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.0 | 0.3 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |